| Literature DB >> 35076177 |
Maria Suñol1, Michael F Payne2, Han Tong3, Thomas C Maloney4, Tracy V Ting3, Susmita Kashikar-Zuck3, Robert C Coghill3, Marina López-Solà1.
Abstract
OBJECTIVE: Juvenile fibromyalgia (FM) is a prevalent chronic pain condition affecting children and adolescents worldwide during a critical period of brain development. To date, no published studies have addressed the pathophysiology of juvenile FM. This study was undertaken to characterize gray matter volume (GMV) alterations in juvenile FM patients for the first time, and to investigate their functional and clinical relevance.Entities:
Mesh:
Year: 2022 PMID: 35076177 PMCID: PMC9247027 DOI: 10.1002/art.42073
Source DB: PubMed Journal: Arthritis Rheumatol ISSN: 2326-5191 Impact factor: 15.483
Figure 1Regions of significantly reduced gray matter volume (GMV) in adolescents with juvenile fibromyalgia (JFM) compared to healthy controls (HCs). Left, Violin plots of the beta weights of the anterior midcingulate cortex (aMCC) cluster in healthy controls and patients with juvenile FM. In the top panel, each box represents the 25th to 75th percentiles. Lines inside the boxes represent the median. Lines outside the boxes represent the 10th and 90th percentiles. Circles indicate outliers. In the bottom panel, circles indicate individual subjects. * = P < 0.01. Middle, Brain maps showing significant between‐group GMV differences (contrast: juvenile FM patients < healthy controls). Results are presented at a significance level of family‐wise error corrected P (P FWE‐corr) < 0.05, estimated using the threshold‐free cluster enhancement (TFCE) approach, and uncorrected P (P uncorr) < 0.001 with a cluster extent (Ke) >50 voxels. Right, The 10 functional annotations most associated with the unthresholded t‐map, obtained by meta‐analytic decoding using Neurosynth. R = right; SMA = supplementary motor area.
Figure 2GMV changes associated with clinical symptoms in adolescents with juvenile FM. Brain maps show significant correlations between GMV and clinical symptoms reflecting disease‐related functional interference in adolescents with juvenile FM, including functional disability as measured by the Functional Disability Inventory (FDI), fatigue as measured by Patient‐Reported Outcomes Measurement Information System (PROMIS), and pain interference as measured by the Brief Pain Inventory (BPI). Results are presented at a significance level of P FWE‐corr < 0.05 (GMV increases shown in yellow) and P uncorr < 0.001 with Ke >50 voxels (GMV increases shown in red). We did not observe negative correlations at the P FWE‐corr or P uncorr level. The 10 functional annotations most associated with the corresponding unthresholded t‐map, obtained by meta‐analytic decoding using Neurosynth, are shown to the right of each brain map. L = left; IFG = inferior frontal gyrus; MFG = middle frontal gyrus; ITC = inferior temporal cortex; SFC = superior frontal cortex (see Figure 1 for other definitions).
Demographic and clinical characteristics of the patients with juvenile FM and healthy controls*
| Controls (n = 38) | Patients with juvenile FM (n = 34) | t/LRV | |
|---|---|---|---|
| Demographic characteristic | |||
| Age, years | 15.89 ± 1.32 | 16.37 ± 1.07 | −1.67 |
| Race, no. Caucasian/non‐Caucasian | 35/3 | 32/2 | 0.11 |
| Annual household income (scale 1–6) | 5.13 ± 2.07 | 5.09 ± 2.02 | 0.09 |
| Education level of caregiver 1 (scale 1–5) | 3.97 ± 0.88 | 3.88 ± 0.91 | 0.43 |
| Education level of caregiver 2 (scale 1–5) | 3.74 ± 0.78 | 3.63 ± 0.98 | 0.55 |
| Brain | |||
| Total GMV volume | 787.70 ± 59.87 | 785.50 ± 53.17 | 0.16 |
| Total WMV | 384.27 ± 40.42 | 399.49 ± 36.89 | −1.66 |
| Clinical variables | |||
| Functional disability (FDI) | 0.5 ± 1.25 | 22.74 ± 9.26 | −13.89 |
| Fatigue (PROMIS) | 14.28 ± 6.64 | 35.23 ± 6.87 | −12.30 |
| Pain interference (BPI) | – | 4.29 ± 1.55 | – |
| Average pain intensity | – | 5.43 ± 1.42 | – |
| Medication, no. (%) | |||
| Pain‐related drugs# | – | 12 (35.29) | – |
| Psychiatric drugs | – | 15 (44.12) | – |
| Gastrointestinal drugs | – | 7 (20.59) | – |
| Melatonin | – | 3 (8.82) | – |
| Antihistamines | – | 3 (8.82) | – |
| Vitamins/iron supplements | – | 3 (8.82) | – |
| Birth control | 2 (5.26) | 2 (5.88) | – |
| Hypertension treatment | 1 (2.63) | – | – |
| Statins | 1 (2.63) | – | – |
Except where indicated otherwise, values are the mean ± SD. FM = fibromyalgia; GMV = gray matter volume; WMV = white matter volume; FDI = Functional Disability Inventory; PROMIS = Patient‐Reported Outcomes Measurement Information System; BPI = Brief Pain Inventory.
Likelihood ratio value (LRV).
Annual household income is shown using a scale of 1–6, where 1 = <$24,999; 2 = $25,000 to $49,999; 3 = $50,000 to $74,999; 4 = $75,000 to $99,000; 5 = $100,000 to $124,999; and 6 = >$125,000.
Caregiver education level is shown using a scale of 1–5, where 1 = less than high school; 2 = high school/GED; 3 = partial college or trade school; 4 = college graduate; 5 = postgraduate degree.
Significant values (P < 0.001).
# Pain‐related drugs included antiepileptic drugs, nonsteroidal antiinflammatory drugs, muscle relaxants, acetaminophen, and/or acetylsalicylic acid.
Psychiatric drugs included antidepressants, anxiolytics, and attention deficit hyperactivity disorder drugs.
Gastrointestinal drugs included antiacids, antireflux drugs, and constipation drugs.
Results of the whole‐brain voxel‐based morphometry analyses*
| Brain region | x, y, z | T | Cluster size, voxels | |
|---|---|---|---|---|
| Structural results at | ||||
| GMV differences between adolescents with juvenile FM and controls | ||||
| Contrast: juvenile FM < controls | aMCC R | 9, 22, 30 | 1018.43 | 113 |
| Correlations between GMV and clinical symptoms in adolescents with juvenile FM | ||||
| Functional disability (FDI) | ||||
| ↑GMV | IFG pars triangularis L | −54, 22, 4 | 1784.78 | 340 |
| Structural results at | ||||
| GMV differences between adolescents with juvenile FM and controls | ||||
| Contrast: juvenile FM < controls | aMCC R | 9, 22, 30 | 4.14 | 983 |
| Correlations between GMV and clinical symptoms in adolescents with juvenile FM | ||||
| Functional disability (FDI) | ||||
| ↑GMV | IFG pars triangularis L | −54, 22, 4 | 6.47 | 805 |
| ↑GMV | IFG pars opercularis R | 57, 14, 15 | 4.35 | 242 |
| ↑GMV | MFG L | −42, 12, 48 | 4.13 | 191 |
| ↑GMV | IFG pars orbitalis R | 42, 21, −14 | 3.81 | 117 |
| Fatigue (PROMIS) | ||||
| ↑GMV | Inferior temporal cortex L | −60, −16, −33 | 5.03 | 115 |
| ↑GMV | IFG pars triangularis L | −54, 26, −3 | 4.83 | 317 |
| ↑GMV | IFG pars orbitalis R | 32, 27, −21 | 4.63 | 366 |
| ↑GMV | IFG pars triangularis L | −50, 28, 9 | 4.54 | 82 |
| ↑GMV | IFG pars orbitalis L | −30, 21, −20 | 4.18 | 76 |
| Pain interference (BPI) | ||||
| ↑GMV | IFG pars triangularis L | −38, 26, 10 | 4.97 | 157 |
| ↑GMV | IFG pars opercularis R | 52, 16, 12 | 4.21 | 264 |
| ↑GMV | Superior frontal cortex R | 28, −3, 66 | 4.11 | 154 |
P FWE‐corr = family wise error rate–corrected P value; GMV = gray matter volume; FM = fibromyalgia; aMCC = anterior midcingulate cortex; R = right; FDI = Functional Disability Inventory; IFG = inferior frontal gyrus; L = left; P uncorr = uncorrected P value; MFG = middle frontal gyrus; PROMIS = Patient‐Reported Outcomes Measurement Information System; BPI = Brief Pain Inventory.
Anatomic coordinates (x, y, z) are given in Montreal Neurological Institute space.
Voxel size 1.5 × 1.5 × 1.5 mm.
Threshold‐free cluster enhancement (TFCE) values.
Figure 3Differences in the similarity between brain structure and a validated pain‐predictive pattern in anterior midcingulate cortex (aMCC)–dorsal medial frontal cortex (dMFC) circuits in patients with juvenile fibromyalgia (JFM) compared to healthy adolescents. The anatomic aMCC–dMFC pattern resembled the functional pain pattern significantly less in juvenile FM patients than in healthy adolescents (t = 2.47, P = 0.016). We found no between‐group differences in the patterns predicting cognitive control and negative emotion within the aMCC–dMFC (all P > 0.05). Bars show the mean ± SEM. * = P < 0.02.
Figure 4Replication in juvenile fibromyalgia (JFM) of meta‐analytic gray matter volume (GMV) alterations observed in adults with FM. A, Peaks of GMV altered in both adults with FM and adolescents with juvenile FM (all P < 0.03). Notably, the GMV at these peaks was decreased in both adult and juvenile forms of FM. Three associated functional annotations, obtained by meta‐analytic decoding using Neurosynth, are shown for each region. B, Peaks of GMV altered in adults with FM but not in adolescents with juvenile FM (all P > 0.4). Bars show the mean ± SEM. * = P < 0.03. L = left; R = right; dACC = dorsal anterior cingulate cortex; PCC = posterior cingulate cortex; NS = not significant (P > 0.05).